United States. Bio-Gate AG, provider of individual solutions for health and hygiene, concludes a preliminary agreement (LOI, letter of intent) with a North American medical device manufacturer focused on the trauma sector.
The medical device manufacturer intends to use Bio-Gate's 'HyProtectTM' coating process for its own implants in human medicine following the FDA approval process.
With the North American medical device manufacturer, Bio-Gate has gained another major company as a partner for its 'HyProtect' coating technology and can develop significant growth potential in applications for human medicine in the future.
The repeatedly documented interest in Bio-Gate's 'HyProtect' coating is strong evidence of the technology's great relevance.
Bio-Gate uses 'HyProtect' technology to coat medical devices with an ultra-thin layer containing polysiloxane and silver.
The release of silver ions provides an antibacterial effect without altering the properties of the product, such as biocompatibility or biomechanical behavior.
The infection data on the use of HyProtect are very positive, especially for implants in individual cases in human medicine and also for serial production implants in veterinary medicine.
